823 related articles for article (PubMed ID: 20022117)
1. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia.
Rogers S; McIntosh RL; Cheung N; Lim L; Wang JJ; Mitchell P; Kowalski JW; Nguyen H; Wong TY;
Ophthalmology; 2010 Feb; 117(2):313-9.e1. PubMed ID: 20022117
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study.
Ponto KA; Elbaz H; Peto T; Laubert-Reh D; Binder H; Wild PS; Lackner K; Pfeiffer N; Mirshahi A
J Thromb Haemost; 2015 Jul; 13(7):1254-63. PubMed ID: 25894549
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, pattern and risk factors of retinal vein occlusion in an elderly population in Nepal: the Bhaktapur retina study.
Thapa R; Bajimaya S; Paudyal G; Khanal S; Tan S; Thapa SS; van Rens G
BMC Ophthalmol; 2017 Sep; 17(1):162. PubMed ID: 28865424
[TBL] [Abstract][Full Text] [Related]
4. Primary angle closure and primary angle closure glaucoma in retinal vein occlusion.
Xu K; Wu L; Ma Z; Liu Y; Qian F
Acta Ophthalmol; 2019 May; 97(3):e364-e372. PubMed ID: 30239140
[TBL] [Abstract][Full Text] [Related]
5. Retinal Vein Occlusion in a Multi-Ethnic Asian Population: The Singapore Epidemiology of Eye Disease Study.
Koh V; Cheung CY; Li X; Tian D; Wang JJ; Mitchell P; Cheng CY; Wong TY
Ophthalmic Epidemiol; 2016; 23(1):6-13. PubMed ID: 26751637
[TBL] [Abstract][Full Text] [Related]
6. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors.
Song P; Xu Y; Zha M; Zhang Y; Rudan I
J Glob Health; 2019 Jun; 9(1):010427. PubMed ID: 31131101
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 3. Retinal vascular occlusion in patients with type 2 diabetes mellitus.
Bhattacharjee H; Barman M; Misra D; Multani PK; Dhar S; Behera UC; Das T; Gilbert C; Murthy GVS; Rajalakshmi R; Pant HB;
Indian J Ophthalmol; 2020 Feb; 68(Suppl 1):S27-S31. PubMed ID: 31937725
[TBL] [Abstract][Full Text] [Related]
8. The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study.
Zhou JQ; Xu L; Wang S; Wang YX; You QS; Tu Y; Yang H; Jonas JB
Ophthalmology; 2013 Apr; 120(4):803-8. PubMed ID: 23352194
[TBL] [Abstract][Full Text] [Related]
9. Retinal vein occlusion and chronic kidney disease: A meta-analysis.
Fang LJ; Dong L; Li YF; Wei WB
Eur J Ophthalmol; 2021 Jul; 31(4):1945-1952. PubMed ID: 32578456
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study.
Mitchell P; Smith W; Chang A
Arch Ophthalmol; 1996 Oct; 114(10):1243-7. PubMed ID: 8859084
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of visual prognosis and correlative factors in retinal vein occlusion].
Zhang H; Xia Y
Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):98-102. PubMed ID: 11955310
[TBL] [Abstract][Full Text] [Related]
12. Retinal vein occlusion in Armenia.
Malayan AS; Shakhsuvaryan ML; Grigoryan GL; Melkonyan AK
Eur J Ophthalmol; 1999; 9(3):196-201. PubMed ID: 10544974
[TBL] [Abstract][Full Text] [Related]
13. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis.
Cheung N; Klein R; Wang JJ; Cotch MF; Islam AF; Klein BE; Cushman M; Wong TY
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4297-302. PubMed ID: 18539932
[TBL] [Abstract][Full Text] [Related]
14. Nine-year incidence and risk factors for retinal vein occlusion in a general Japanese population: the Hisayama Study.
Arakawa S; Yasuda M; Nagata M; Ninomiya T; Hirakawa Y; Doi Y; Kiyohara Y; Ishibashi T
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5905-9. PubMed ID: 21693603
[TBL] [Abstract][Full Text] [Related]
15. Hematologic abnormalities associated with various types of retinal vein occlusion.
Hayreh SS; Zimmerman MB; Podhajsky P
Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):180-96. PubMed ID: 11935275
[TBL] [Abstract][Full Text] [Related]
16. Baseline characteristics and risk factors of retinal vein occlusion: a study by the Korean RVO Study Group.
Lee JY; Yoon YH; Kim HK; Yoon HS; Kang SW; Kim JG; Park KH; Jo YJ;
J Korean Med Sci; 2013 Jan; 28(1):136-44. PubMed ID: 23341724
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and associated factors of retinal vein occlusion in the Korean National Health and Nutritional Examination Survey, 2008-2012: A cross-sectional observational study.
Shin YU; Cho H; Kim JM; Bae K; Kang MH; Shin JP; Nam E; Kang SW;
Medicine (Baltimore); 2016 Nov; 95(44):e5185. PubMed ID: 27858854
[TBL] [Abstract][Full Text] [Related]
18. Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion.
Pinna A; Carru C; Solinas G; Zinellu A; Carta F
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2747-52. PubMed ID: 17525208
[TBL] [Abstract][Full Text] [Related]
19. Impact of cardiovascular risk factors on incidence and severity of Retinal Vein Occlusion.
Pacella F; Bongiovanni G; Malvasi M; Trovato Battagliola E; Pistone A; Scalinci SZ; Basili S; La Torre G; Pacella E
Clin Ter; 2020; 171(6):e534-e538. PubMed ID: 33151253
[TBL] [Abstract][Full Text] [Related]
20. Aqueous semaphorin 3A level correlates with retinal macular oedema and ganglion cell degeneration in patients with retinal vein occlusion.
Guo S; Ren J; Li Z; Fan X; Qin L; Li J
Acta Ophthalmol; 2019 May; 97(3):273-278. PubMed ID: 30803163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
